Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+1829Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+3841Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+5520Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+6022Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+H)+Peak areaPAK Untreated
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+1361Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+1869Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODECITRULLINE (CAS# 372-75-8); (M+NA)+Peak areaPAK Untreated

Return to search page
  logo